| 1 |
33570057 | Rhamnetin decelerates the elimination and enhances the antitumor effect of the molecular-targeting agent sorafenib in hepatocellular carcinoma cells via the miR-148a/PXR axis. | 2021 Mar 21 |
1 |
| 2 |
24797816 | Sorafenib metabolism is significantly altered in the liver tumor tissue of hepatocellular carcinoma patient. | 2014 |
2 |
| 3 |
22513143 | Role of human CYP3A4 in the biotransformation of sorafenib to its major oxidized metabolites. | 2012 Jul 15 |
3 |
| 4 |
22927483 | Ontogeny and sorafenib metabolism. | 2012 Oct 15 |
2 |
| 5 |
21350850 | Interaction of sorafenib and cytochrome P450 isoenzymes in patients with advanced melanoma: a phase I/II pharmacokinetic interaction study. | 2011 Nov |
2 |